Clinical trial
Effects of Short-chain Fatty Acids, Here Sodium Propionate, a Metabolism Product of the Human Gut-microbiome, on Inflammatory and Metabolic Parameters in Patients on Maintenance Hemodialysis - a Pilot Study
NCT02976688 is registered in ClinicalTrials.gov with Azienda Sanitaria ASL Avellino 2 as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Short-chain Fatty Acids, Here Sodium Propionate, a Metabolism Product of the Human Gut-microbiome, on Inflammatory and Metabolic Parameters in Patients on Maintenance Hemodialysis - a Pilot Study
- Lead sponsor
- Azienda Sanitaria ASL Avellino 2
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- December 31, 2017
- Enrollment
- 15 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
endstage renal disease